StockDriftsStockDriftsTop 41 Ishara Investments LP Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| ACAD | ACADIA PHARMACEUTICALS INC | 7.62% | 410.0K | $10.4M | +233.33%(+287.00K) | $23.44(+21.09%) | 2026-06-30 | |
| XERS | XERIS BIOPHARMA HOLDINGS INC | 7.16% | 1.23M | $9.7M | +20.00%(+205.00K) | $7.58(+9.96%) | 2026-06-30 | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 6.03% | 143.5K | $8.2M | +75.00%(+61.50K) | $56.46(+21.39%) | 2026-06-30 | |
| PRAX | PRAXIS PRECISION MEDICINES I | 5.55% | 22.6K | $7.5M | +0.00%(+0) | $173.87(+119.27%) | 2026-06-30 | |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 5.03% | 205.0K | $6.8M | +17.65%(+30.75K) | $23.74(+11.90%) | 2026-06-30 | |
| AGIO | AGIOS PHARMACEUTICALS INC | 4.47% | 164.0K | $6.1M | new | $33.42(+0.15%) | 2026-06-30 | |
| INSM | INSMED INC | 4.01% | 51.3K | $5.5M | new | $135.64(-6.86%) | 2026-06-30 | |
| CRNX | CRINETICS PHARMACEUTICALS IN | 3.95% | 143.5K | $5.4M | new | $35.84(+136.24%) | 2026-06-30 | |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 3.65% | 1.02M | $5.0M | -16.67%(-205.00K) | $1.43(+190.21%) | 2026-06-30 | |
| PCVX | VAXCYTE INC | 3.5% | 82.0K | $4.8M | +42.86%(+24.60K) | $46.72(+28.16%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (2 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — | +18.03% |
| Top 20 Holdings Unweighted | — | — | — | — | +19.39% |
Ishara Investments LP reports $136.10M in US-listed equity holdings across 41 positions in its most recent 13F filing. Its largest disclosed positions are ACAD (7.6%), XERS (7.2%) and BMRN (6.0%). The top 20 holdings account for 78.32% of reported assets. Its disclosed equity book has returned +18.03% cumulatively over 2 quarters. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Ishara Investments LP, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Ishara Investments LP’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 2111609). View Ishara Investments LP’s 13F filings on SEC